T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 97169)

Published in Infect Immun on February 01, 2000

Authors

W L Chang1, R G Audet, B D Aizenstein, L H Hogan, R I DeMars, B S Klein

Author Affiliations

1: Department of Internal Medicine, Louisiana State University Medical School, Shreveport, Louisiana 71103, USA.

Articles cited by this

Two populations of Ia-like molecules on a human B cell line. J Immunol (1980) 7.68

Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science (1991) 3.58

Quantitative plating of Histoplasma capsulatum without addition of conditioned medium or siderophores. J Med Vet Mycol (1988) 3.24

Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med (1986) 2.87

Detection of a novel human class II HLA antigen. Nature (1983) 2.61

The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immunol (1995) 1.91

Targeted gene disruption reveals an adhesin indispensable for pathogenicity of Blastomyces dermatitidis. J Exp Med (1999) 1.67

Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients. J Clin Invest (1990) 1.46

Immunologic recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis. J Clin Invest (1993) 1.18

Chlamydia trachomatis major outer membrane protein (MOMP) epitopes that activate HLA class II-restricted T cells from infected humans. J Immunol (1996) 1.16

How the MHC selects Th1/Th2 immunity. Immunol Today (1998) 1.16

Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts. J Biol Chem (1995) 1.15

T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest (1996) 1.14

Cell-mediated immunoprotection in blastomycosis. Infect Immun (1980) 1.11

Blastomycosis in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1992) 1.09

A protective domain of heat-shock protein 60 from Histoplasma capsulatum. J Infect Dis (1996) 1.08

Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect Immun (1998) 1.06

Blastomycosis in immunocompromised patients. Medicine (Baltimore) (1993) 1.04

Prospects for the development of fungal vaccines. Clin Microbiol Rev (1997) 1.02

WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis. Infect Immun (1992) 1.00

Purification in quantity of the secreted form of WI-1: a major adhesin on Blastomyces dermatitidis yeasts. Protein Expr Purif (1997) 0.93

Isolation of heavy chain class switch variants of a monoclonal anti-DC1 hybridoma cell line: effective conversion of noncytotoxic IgG1 antibodies to cytotoxic IgG2 antibodies. Hum Immunol (1983) 0.92

HLA-DP--part of the concert. Immunol Today (1997) 0.81

Differences in specificity of "DPw2-specific" cytotoxic T cell clones revealed with HLA-mutant lines: evidence that non-DP HLA genes influence recognition by some clones. Eur J Immunol (1990) 0.77

Articles by these authors

Isolation of Blastomyces dermatitidis in soil associated with a large outbreak of blastomycosis in Wisconsin. N Engl J Med (1986) 2.87

Recognition by human V gamma 9/V delta 2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science (1990) 2.25

The WI-1 antigen of Blastomyces dermatitidis yeasts mediates binding to human macrophage CD11b/CD18 (CR3) and CD14. J Immunol (1995) 1.91

Nosocomial Pseudomonas pickettii bacteremias traced to narcotic tampering. A case for selective drug screening of health care personnel. JAMA (1991) 1.86

Virulence factors of medically important fungi. Clin Microbiol Rev (1996) 1.83

Altered expression of surface alpha-1,3-glucan in genetically related strains of Blastomyces dermatitidis that differ in virulence. Infect Immun (1994) 1.57

Campylobacter infection associated with raw milk. An outbreak of gastroenteritis due to Campylobacter jejuni and thermotolerant Campylobacter fetus subsp fetus. JAMA (1986) 1.37

Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance. J Clin Invest (2000) 1.27

ARFI-based tissue elasticity quantification in comparison to histology for the diagnosis of renal transplant fibrosis. Clin Hemorheol Microcirc (2010) 1.22

Immunologic recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis. J Clin Invest (1993) 1.18

Genomic cloning, characterization, and functional analysis of the major surface adhesin WI-1 on Blastomyces dermatitidis yeasts. J Biol Chem (1995) 1.15

The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis. J Immunol (2001) 1.08

Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis. Infect Immun (1998) 1.06

Selective expression of the virulence factor BAD1 upon morphogenesis to the pathogenic yeast form of Blastomyces dermatitidis: evidence for transcriptional regulation by a conserved mechanism. Mol Microbiol (2001) 1.06

Blastomycosis in solid organ transplant recipients. Transpl Infect Dis (2007) 1.04

The role of respiratory syncytial virus and other viral pathogens in acute otitis media. J Pediatr (1982) 1.03

Nosocomial hepatitis A. A multinursery outbreak in Wisconsin. JAMA (1984) 1.01

Flow cytometric quantitation of yeast a novel technique for use in animal model work and in vitro immunologic assays. J Immunol Methods (1998) 0.99

Serological tests for blastomycosis: assessments during a large point-source outbreak in Wisconsin. J Infect Dis (1987) 0.98

Altered expression of surface protein WI-1 in genetically related strains of Blastomyces dermatitidis that differ in virulence regulates recognition of yeasts by human macrophages. Infect Immun (1994) 0.98

Transforming DNA integrates at multiple sites in the dimorphic fungal pathogen Blastomyces dermatitidis. Gene (1997) 0.98

Development and application of a green fluorescent protein sentinel system for identification of RNA interference in Blastomyces dermatitidis illuminates the role of septin in morphogenesis and sporulation. Eukaryot Cell (2007) 0.92

Comparison of the enzyme immunoassay, immunodiffusion, and complement fixation tests in detecting antibody in human serum to the A antigen of Blastomyces dermatitidis. Am Rev Respir Dis (1986) 0.91

Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast. Infect Immun (2001) 0.91

Variable and conserved structural elements of trypanosome variant surface glycoproteins. Mol Biochem Parasitol (1992) 0.90

Membrane-bound mRNAs are recruited from preinitiated ribonucleoprotein particles in injected Xenopus oocytes. J Biol Chem (1985) 0.87

Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis. J Infect Dis (2000) 0.86

ARFI-based tissue elasticity quantification and kidney graft dysfunction: first clinical experiences. Clin Hemorheol Microcirc (2011) 0.86

African strains of Blastomyces dermatitidis that do not express surface adhesin WI-1. Infect Immun (1997) 0.85

Eukaryotic initiation factor 4A stimulates translation in microinjected Xenopus oocytes. Dev Biol (1987) 0.85

Follow-up on a human X-autosome translocation first studied in 1963 and 1964. Birth Defects Orig Artic Ser (1978) 0.83

Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulin G antibodies, and enhances protective immunity to Blastomyces dermatitidis infection. Infect Immun (2000) 0.80

Utility of anti-WI-1 serological testing in the diagnosis of blastomycosis in Wisconsin residents. Clin Infect Dis (1994) 0.78

Apolipoprotein E is a putative autocrine regulator of the rat ovarian theca cell compartment. Biol Reprod (2001) 0.78

A laboratory-based surveillance of human blastomycosis in Wisconsin between 1973 and 1982. Am J Epidemiol (1985) 0.76

Kawasaki syndrome: a controlled study of an outbreak in Wisconsin. Am J Epidemiol (1986) 0.76

Implications of intermediaries in podiatry. J Am Podiatry Assoc (1969) 0.75

The origin of telocentric chromosomes in man: a girl with tel(Xq). Hum Genet (1981) 0.75

Phenotypic expression in T-lymphocyte x "fibroblast" cell hybrids. Curr Top Microbiol Immunol (1978) 0.75

Diet education for the parents of a young child with diabetes. Diabetes Educ (1984) 0.75